今天盘前有新闻The company said the trial of CAP-1002 demonstrated "a low probability" of achieving a statistically-significant difference in the primary endpoint of change from baseline scar size.抄底谨慎啊
是啊9号才增持，今天就跌，应该可以抄底啦
![[为什么]](http://assets.imedao.com/ugc/images/face/emoji_14_doubt.png?v=1 "[为什么]"){kind=small}